Literature DB >> 27233497

The importance of the excitatory amino acid transporter 3 (EAAT3).

Walden E Bjørn-Yoshimoto1, Suzanne M Underhill2.   

Abstract

The neuronal excitatory amino acid transporter 3 (EAAT3) is fairly ubiquitously expressed in the brain, though it does not necessarily maintain the same function everywhere. It is important in maintaining low local concentrations of glutamate, where its predominant post-synaptic localization can buffer nearby glutamate receptors and modulate excitatory neurotransmission and synaptic plasticity. It is also the main neuronal cysteine uptake system acting as the rate-limiting factor for the synthesis of glutathione, a potent antioxidant, in EAAT3 expressing neurons, while on GABAergic neurons, it is important in supplying glutamate as a precursor for GABA synthesis. Several diseases implicate EAAT3, and modulation of this transporter could prove a useful therapeutic approach. Regulation of EAAT3 could be targeted at several points for functional modulation, including the level of transcription, trafficking and direct pharmacological modulation, and indeed, compounds and experimental treatments have been identified that regulate EAAT3 function at different stages, which together with observations of EAAT3 regulation in patients is giving us insight into the endogenous function of this transporter, as well as the consequences of altered function. This review summarizes work done on elucidating the role and regulation of EAAT3. Published by Elsevier Ltd.

Entities:  

Keywords:  EAAT3; Glutamate transporter

Mesh:

Substances:

Year:  2016        PMID: 27233497      PMCID: PMC4969196          DOI: 10.1016/j.neuint.2016.05.007

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  238 in total

1.  Neutralizing aspartate 83 modifies substrate translocation of excitatory amino acid transporter 3 (EAAT3) glutamate transporters.

Authors:  Jasmin Hotzy; Jan-Philipp Machtens; Christoph Fahlke
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

2.  Energy metabolism in glutamatergic neurons, GABAergic neurons and astrocytes in primary cultures.

Authors:  L Hertz; J Drejer; A Schousboe
Journal:  Neurochem Res       Date:  1988-07       Impact factor: 3.996

3.  Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate.

Authors:  J W Olney
Journal:  Science       Date:  1969-05-09       Impact factor: 47.728

4.  Pertussis toxin-sensitive modulation of glutamate transport by endothelin-1 type A receptors in glioma cells.

Authors:  Mustapha Najimi; Jean-Marie Maloteaux; Emmanuel Hermans
Journal:  Biochim Biophys Acta       Date:  2005-01-22

Review 5.  Applications of the Morris water maze in the study of learning and memory.

Authors:  R D'Hooge; P P De Deyn
Journal:  Brain Res Brain Res Rev       Date:  2001-08

6.  Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia.

Authors:  Parisa Afshari; Marina Myles-Worsley; Ori S Cohen; Josepha Tiobech; Stephen V Faraone; William Byerley; Frank A Middleton
Journal:  Mol Neuropsychiatry       Date:  2015-07-08

7.  Rapid trafficking of the neuronal glutamate transporter, EAAC1: evidence for distinct trafficking pathways differentially regulated by protein kinase C and platelet-derived growth factor.

Authors:  Keith M Fournier; Marco I González; Michael B Robinson
Journal:  J Biol Chem       Date:  2004-06-14       Impact factor: 5.157

8.  Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder.

Authors:  S Evelyn Stewart; Jesen A Fagerness; Jill Platko; Jordan W Smoller; Jeremiah M Scharf; Cornelia Illmann; Eric Jenike; Nadia Chabane; Marion Leboyer; Richard Delorme; Michael A Jenike; David L Pauls
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-12-05       Impact factor: 3.568

Review 9.  A Framework for Understanding the Emerging Role of Corticolimbic-Ventral Striatal Networks in OCD-Associated Repetitive Behaviors.

Authors:  Jesse Wood; Susanne E Ahmari
Journal:  Front Syst Neurosci       Date:  2015-12-17

10.  GTRAP3-18 serves as a negative regulator of Rab1 in protein transport and neuronal differentiation.

Authors:  S Maier; V Reiterer; A M Ruggiero; J D Rothstein; S Thomas; R Dahm; H H Sitte; H Farhan
Journal:  J Cell Mol Med       Date:  2008-03-14       Impact factor: 5.310

View more
  25 in total

1.  OCD candidate gene SLC1A1/EAAT3 impacts basal ganglia-mediated activity and stereotypic behavior.

Authors:  Isaac D Zike; Muhammad O Chohan; Jared M Kopelman; Emily N Krasnow; Daniel Flicker; Katherine M Nautiyal; Michael Bubser; Christoph Kellendonk; Carrie K Jones; Gregg Stanwood; Kenji Fransis Tanaka; Holly Moore; Susanne E Ahmari; Jeremy Veenstra-VanderWeele
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-15       Impact factor: 11.205

2.  Perinatal high fat diet and early life methyl donor supplementation alter one carbon metabolism and DNA methylation in the brain.

Authors:  Sarah E McKee; Sisi Zhang; Li Chen; Joshua D Rabinowitz; Teresa M Reyes
Journal:  J Neurochem       Date:  2018-04-16       Impact factor: 5.372

Review 3.  Effect of supplementation with methyl-donor nutrients on neurodevelopment and cognition: considerations for future research.

Authors:  Sarah E McKee; Teresa M Reyes
Journal:  Nutr Rev       Date:  2018-07-01       Impact factor: 7.110

Review 4.  The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.

Authors:  Edward Pajarillo; Asha Rizor; Jayden Lee; Michael Aschner; Eunsook Lee
Journal:  Neuropharmacology       Date:  2019-03-06       Impact factor: 5.250

5.  Animal Models for OCD Research.

Authors:  Brittany L Chamberlain; Susanne E Ahmari
Journal:  Curr Top Behav Neurosci       Date:  2021

6.  Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy.

Authors:  Aleksey V Zaitsev; Ilya V Smolensky; Pascal Jorratt; Saak V Ovsepian
Journal:  CNS Drugs       Date:  2020-11       Impact factor: 5.749

Review 7.  EAAT2 as a Research Target in Bipolar Disorder and Unipolar Depression: A Systematic Review.

Authors:  Caren J Blacker; Vincent Millischer; Lauren M Webb; Ada M C Ho; Martin Schalling; Mark A Frye; Marin Veldic
Journal:  Mol Neuropsychiatry       Date:  2019-07-23

8.  Progesterone treatment following traumatic brain injury in the 11-day-old rat attenuates cognitive deficits and neuronal hyperexcitability in adolescence.

Authors:  Dana Lengel; Jimmy W Huh; Jessica R Barson; Ramesh Raghupathi
Journal:  Exp Neurol       Date:  2020-04-23       Impact factor: 5.330

Review 9.  Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug Abuse.

Authors:  Sade Spencer; Peter W Kalivas
Journal:  Int J Neuropsychopharmacol       Date:  2017-10-01       Impact factor: 5.176

10.  Glutamate as a potential "survival factor" in an in vitro model of neuronal hypoxia/reoxygenation injury: leading role of the Na+/Ca2+ exchanger.

Authors:  Silvia Piccirillo; Pasqualina Castaldo; Maria Loredana Macrì; Salvatore Amoroso; Simona Magi
Journal:  Cell Death Dis       Date:  2018-06-28       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.